Alacrita Life Science Consulting Alacrita Life Science Consulting
  • Our Services
    • Product Development
      • Research & IP Evaluation
      • Preclinical Strategy & Execution
      • Clinical Development
      • Regulatory Affairs
      • CMC Consulting
    • Strategy & Commercialization
      • Opportunity Mapping
      • Business Plans & Fundraising Support
      • New Product Planning
      • Launch Planning
    • Business Development
      • Asset Scouting
      • Due Diligence
      • Pharma & Biotech Valuations
      • Partnering & Deal-making
    • By Client Type
      • Biotech
      • Pharmaceutical Companies
      • Investors
      • Research Institutes & Academia
  • People
    • Anthony Walker
    • Simon Turner
    • Alastair Southwell
    • Saadia Basharat
    • Chris Owens
    • Jess Hearn
    • Eugene Mironets
    • Lucas Rodriguez
    • William (Bill) Slichenmyer
    • Mark Philip
    • Christine McCarthy
    • Stuart Hendry
    • Pierre Dodion
    • Michael Esposito
    • Brian Machinist
  • Expert Network
  • Resources
    • Case Studies
    • Blog
    • News
    • Whitepapers
  • Careers
  • Contact

Biotech & Pharmaceutical Consulting

pharma licensing

These selected case studies illustrate the scope of our work, the level of expertise we’re able to offer, and our consistent record of successful engagements.

  • why us?
  • Case Studies
  • pharma licensing
  • All
  • Business Development
  • Product Development
  • Due Diligence
  • Strategy & Commercialization
  • Regulatory Affairs
  • Clinical Development
  • Valuations
  • Opportunity Mapping
  • Research and IP evaluation
  • Asset Scouting
  • Business Strategy
  • New Product Planning
  • Immunotherapy
  • Partnering and deal-making
  • Antibodies, ADCs
  • Cell & Gene Therapy
  • Pharma Consulting
  • Oncology
  • Launch Planning
  • Preclinical Development
  • Pharma Licensing
  • Expert Witness
  • Gene Therapy
  • Partnering & Deal-making

Deal analysis for an anti-anaemia product

Challenge: A Middle East investor group was facing its first potential deal in the pharmaceuticals sector. It had pre-negotiated a deal with a group that had invented an approach to treating...
Learn More

Valuation of EPP drug to support in-licensing negotiation

Challenge: A privately capitalized biotech company in US, which was developing a pipeline of novel drugs to impact iron metabolism, wanted help with the valuation of in licensing opportunity for a...
Learn More
1

Need biotech consulting support? We can help.

Contact us today to learn how our pharma & biotech consulting expertise can serve your project.

Contact us

Explore our biotech & life science consulting services

  • Strategy and Commercialization Learn more
  • Product Development Learn more
  • Business Development Learn more

© 2022 Alacrita Holdings Limited  |   Pharma & Biotech Consulting

  • Privacy Notice

Alacrita Life Science Consulting 
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608


One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.

Alacrita Life Science Consulting Alacrita Life Science Consulting